Ngā hua rapu - Doaa A. Ghareeb
- E whakaatu ana i te 1 - 10 hua o te 10
-
1
Neuroprotective efficacy of berberine and caffeine against rotenone‐induced neuroinflammatory and oxidative disturbances associated with Parkinson’s disease via inhibiting α-synucl... mā Tasnim S. Waheeb, Mohammad A. Abdulkader, Doaa A. Ghareeb, Mohamed E. Moustafa
I whakaputaina 2025Artigo -
2
-
3
Forecasting of potential anti-inflammatory targets of some immunomodulatory plants and their constituents using in vitro, molecular docking and network pharmacology-based analysis mā Asmaa Khairy, Doaa A. Ghareeb, İsmail Çeli̇k, Hala M. Hammoda, Hala H. Zaatout, Reham S. Ibrahim
I whakaputaina 2023Artigo -
4
In vitro biological assessment of berberis vulgaris and its active constituent, berberine: antioxidants, anti-acetylcholinesterase, anti-diabetic and anticancer effects mā Abeer E. Abd El-Wahab, Doaa A. Ghareeb, Eman Sarhan, Marwa M. Abu‐Serie, Maha El Demellawy
I whakaputaina 2013Artigo -
5
The Therapeutic Potential of Two Egyptian Plant Extracts for Mitigating Dexamethasone-Induced Osteoporosis in Rats: Nrf2/HO-1 and RANK/RANKL/OPG Signals mā Samar R. Saleh, Omnia M. Saleh, Ashraf A. El-Bessoumy, Eman Sheta, Doaa A. Ghareeb, Saber M. Eweda
I whakaputaina 2024Artigo -
6
Preparation, physicochemical characterization, and bioactivity evaluation of berberine-entrapped albumin nanoparticles mā Fatema A. Younis, Samar R. Saleh, Sahar S. Abd El‐Rahman, Al‐Sayeda A. Newairy, Maha El Demellawy, Doaa A. Ghareeb
I whakaputaina 2022Artigo -
7
Repurposing 1,2,4-oxadiazoles as SARS-CoV-2 PLpro inhibitors and investigation of their possible viral entry blockade potential mā Mohammed Salah Ayoup, Mariam M. ElShafey, Hamida Abdel‐Hamid, Doaa A. Ghareeb, Marwa M. Abu‐Serie, Lamia Heikal, Mohamed Teleb
I whakaputaina 2023Artigo -
8
Novel sulfonamide derivatives as multitarget antidiabetic agents: design, synthesis, and biological evaluation mā Mohammed Salah Ayoup, Nourhan Khaled, Hamida Abdel‐Hamid, Doaa A. Ghareeb, Samah A. Nasr, Ahmed M. Omer, Amr Sonousi, Asmaa E. Kassab, Abdelazeem S. Eltaweil
I whakaputaina 2024Artigo -
9
New 1,2,4-oxadiazole derivatives as potential multifunctional agents for the treatment of Alzheimer’s disease: design, synthesis, and biological evaluation mā Mohammed Salah Ayoup, Mariam Ghanem, Hamida Abdel‐Hamid, Marwa M. Abu‐Serie, Aliaa A. Masoud, Doaa A. Ghareeb, Mohammed B. Hawsawi, Amr Sonousi, Asmaa E. Kassab
I whakaputaina 2024Artigo -
10
Nanoparticles of ZnO/Berberine complex contract COVID-19 and respiratory co-bacterial infection in addition to elimination of hydroxychloroquine toxicity mā Doaa A. Ghareeb, Samar R. Saleh, Mohamed G. Seadawy, Mohammed S. Nofal, Shaymaa A. Abdulmalek, Salma. F. Hassan, Shaimaa M. Khedr, M.A. Wahab, Ahmed A. Sobhy, Ali S. A. Abdelhamid, Abdelrahman M. Yassin, Alshimaa A. Abd Elmoneam, Aliaa A. Masoud, Mohamed M. Y. Kaddah, Sally A. El‐Zahaby, Abdulaziz Mohsen Al-mahallawi, Alaa M. El-Gharbawy, Ahmed Zaki, Inas K. Seif, Marwa Y. Kenawy, Magdy Amin, Khaled Amer, Maha El Demellawy
I whakaputaina 2021Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Chemistry
Medicine
Biochemistry
Pharmacology
Antioxidant
Biology
Internal medicine
Organic chemistry
Disease
In vitro
Oxidative stress
Traditional medicine
Berberine
Docking (animal)
Endocrinology
Nursing
Oxadiazole
Quercetin
Stereochemistry
Virology
2019-20 coronavirus outbreak
AKT1
Activator (genetics)
Apigenin
Berberis
Bioavailability
Biotechnology
Bone mineral
Bone remodeling
Bone resorption